COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,610 Articles (22,913 medRxiv, 8,697 bioRxiv)

Most recent first Previous |  Page 2694: Articles 26931-26940  | Next

Detection of asymptomatic SARS-CoV-2 exposed individuals by a sensitive S-based ELISA.
Rosendal, E., Wigren, J., Groening, R., Yongdae, K., Nilsson, E., Sharma, A., espaillat, a., Hanke, L., Thunberg, T., McInerney, G., Puhar, A., Cava, F., Karlsson Hedestam, G. B., Monsen, T., Elgh, F., Blomkvist, B., Marklund, I., Ahlm, C., Evander, M., Normark, J., Johansson, A., Overby, A. K., Forsell, M.
10.1101/2020.06.02.20120477 — Posted: 2020-06-04
Assembly of an integrated human lung cell atlas reveals that SARS-CoV-2 receptor is co-expressed with key elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells
Sidarta-Oliveira, D., Poblete Jara, C., Ferruzzi, A. J., Skaf, M. S., Velander, W. H., Araujo, E. P., Velloso, L. A.
10.1101/2020.06.02.20120634 — Posted: 2020-06-04
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
Pickering, S., Betancor, G., Pedro Galao, R., Merrick, B., Signell, A. W., Wilson, H. D., Tan Kia Ik, M., Seow, J., Graham, C., Acors, S., Kouphou, N., Steel, K. J., Hemmings, O., Patel, A., Nebbia, G., Douthwaite, S., O'Connell, L., Luptak, J., McCoy, L., Brouwer, P. J., van Gils, M. J., Sanders, R. W., Martinez Nunez, R., Bisnauthsing, K., O'Hara, G., MacMahon, E., Batra, R., Malim, M. H., Neil, S. J., Doores, K., Edgeworth, J. D.
10.1101/2020.06.02.20120345 — Posted: 2020-06-04
Viral load dynamics in transmissible symptomatic patients with COVID-19
Kawasuji, H., Takegoshi, Y., Kaneda, M., Ueno, A., Miyajima, Y., Kawago, K., Fukui, Y., Yoshida, Y., Kimura, M., Yamada, H., Sakamaki, I., Tani, H., Morinaga, Y., Yamamoto, Y.
10.1101/2020.06.02.20120014 — Posted: 2020-06-04 Discussion: Offsite
The Relationship Between COVID-19 Infection and Risk Perception, Knowledge, Attitude As Well As Four Non-pharmaceutical Interventions (NPIs) During the Late Period Of The COVID-19 Epidemic In China An Online Cross-sectional Survey of 8158 Adults
Xu, H., Gan, Y., Zheng, D., Wu, B., Zhu, X., Xu, C., Liu, C., Tao, Z., Hu, Y., Chen, M., Li, M., Lu, Z., Chen, J.
10.1101/2020.06.02.20120808 — Posted: 2020-06-04
Multi-parametric disease dynamics study and analysis of the COVID-19 epidemic and implementation of population-wide intrusions: The Indian perspective
Bharti, S., Narad, P., Chugh, P., Choudhury, A., Bhatnagar, S., Sengupta, A.
10.1101/2020.06.02.20120360 — Posted: 2020-06-04
Assessing capacity to social distance and neighborhood-level health disparities during the COVID-19 pandemic
Carrion, D., Colicino, E., Foppa Pedretti, N., Rush, J., DeFelice, N., Just, A. C.
10.1101/2020.06.02.20120790 — Posted: 2020-06-04
Trajectories of depression and anxiety during enforced isolation due to COVID-19: longitudinal analyses of 59,318 adults in the UK with and without diagnosed mental illness
Fancourt, D., Steptoe, A., Bu, F.
10.1101/2020.06.03.20120923 — Posted: 2020-06-04
Genetic polymorphisms mediating behavioural and immune response to pathogens may moderate the impact of the COVID-19 pandemic: a pilot study
Rajkumar, R. P.
10.1101/2020.06.03.20120998 — Posted: 2020-06-04
Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing
Takita, M., Matsumura, T., Yamamoto, K., Yamashita, E., Hosoda, K., Hamaki, T., Kusumi, E.
10.1101/2020.06.03.20121020 — Posted: 2020-06-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).